All posts by Simon Carley

Professor Simon Carley MB ChB, PGDip, DipIMC (RCS Ed), FRCS (Ed)(1998), FHEA, FAcadMed, FRCEM, MPhil, MD, PhD is Creator, Webmaster, owner and Editor in Chief of the St Emlyn’s blog and podcast. He is Professor of Emergency Medicine at Manchester Metropolitan University and a Consultant in adult and paediatric Emergency Medicine at Manchester Foundation Trust. He is co-founder of BestBets, St.Emlyns and the MSc in emergency medicine at Manchester Metropolitan University. He is an Education Associate with the General Medical Council and is an Associate Editor for the Emergency Medicine Journal. His research interests include diagnostics, MedEd, Major incidents & Evidence based Emergency Medicine. He is verified on twitter as @EMManchester

JC: Convalescent plasma in COVID 19 patients.

This month the BMJ has published a trial on the use of convalescent plasma in the treatment of admitted patients with COVID-19 (the PLACID trial). Convalescent plasma therapy basically takes plasma, together with antibodies from

CODA Zero episodes now open access.

I’m not sure whether you have noticed, but the first two episodes of the CODA Zero program are now live on their website. If you did not already know, the CODA project is designed to

October 2020

October 2020 round up podcast

October was a busy month with a strong theme of trauma and coagulopathy. Iain and Simon got together to podcast the highlights which you can listen to on the link below, or even better subscribe

Why infection control failures might kill your patients and colleagues. St Emlyn’s

This blog is based upon a short lecture given by Simon Mardel OBE (1,2). He is an emergency physician who has extensive experience in humanitarian work. He has worked in many infectious disease outbreaks around

JC: Early plasma use in traumatic brain injury. St Emlyn’s

There seems to be a lot of really interesting papers on Traumatic Brain Injury (TBI) this year. A welcome relief from COVID 19 perhaps but also a reminder that other pathologies exist and that TBI

JC: Hydroxychloroquine in the the treatment of hospitalised COVID19 patients.

We previously covered the RECOVERY trial press release on the use of HCQ for hospitalised patients with COVID19. This is a UK based platform trial (more on this later) looking at patients admitted to hospital

JC: Antibiotics or Surgery for appendicitis.

Appendicitis is a common problem in the emergency department, and for many years the standard of care has been to perform surgery to resolve it. When I trained in surgery (before transferring to EM) this

Be a better Resuscitationist at #iMEDconference12

This week I am joining the iMED conference 12.0 in Lisbon, Portugal, except I’m not really as I am in my office here in Manchester as a result of the COVID19 pandemic. Lisbon is a

JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s

Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also be using it in mild/moderate

CODA

CODA ZERO update: Gender and Ethics

This week I should be on my way to Australia for the CODA Change conference. For obvious reasons I am not going and am sat at home in Manchester enjoying the last remnants of the


Translate »